Edition:
United States

Therapix Biosciences Ltd (TRPX.OQ)

TRPX.OQ on NASDAQ Stock Exchange Capital Market

5.88USD
12 Dec 2017
Change (% chg)

$0.22 (+3.89%)
Prev Close
$5.66
Open
$5.75
Day's High
$7.12
Day's Low
$5.70
Volume
85,170
Avg. Vol
6,372
52-wk High
$10.90
52-wk Low
$4.42

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.022
Jun '17 0.00 -0.040
Mar '17 0.00 -0.014
FY 2016 Dec '16 0.00 -0.010
Sep '16 0.00 -0.013
Jun '16 0.00 -0.013
Mar '16 0.00 -0.014
FY 2015 Dec '15 0.00 -0.016
Sep '15 0.00 -0.055
Jun '15 0.00 -0.018
Mar '15 0.00 -0.020
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-17 1 0.00 0.00 0.00 --
Year Ending Dec-18 1 0.00 0.00 0.00 --
Earnings (per share)
Year Ending Dec-17 1 -4.14 -4.14 -4.14 --
Year Ending Dec-18 1 -7.02 -7.02 -7.02 --
Sales and Profit Figures in Israel Shekel (ILS);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.83 35.27
P/E High - Last 5 Yrs. 38.34 40.68 45.26
P/E Low - Last 5 Yrs. 38.34 23.56 24.18
Beta -2.54 0.92 0.91
Price to Sales (TTM) -- 3.89 5.83
Price to Book (MRQ) 0.68 4.79 5.62
Price to Tangible Book (MRQ) 2.03 5.67 7.22
Price to Cash Flow (TTM) -- 22.76 24.19
% Owned Institutions -- 0.87 1.41

Dividends

  Company industry sector
Dividend Yield -- 1.57 1.50
Dividend Yield - 5 Year Avg -- 2.17 2.04
Dividend 5 Year Growth Rate -- 4.31 5.26
Payout Ratio(TTM) -- 47.36 46.03

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 6.33 6.84
Sales (TTM) vs TTM 1 Yr. Ago -- 5.20 5.66
Sales - 5 Yr. Growth Rate -- 9.99 10.25
EPS (MRQ) vs Qtr. 1 Yr. Ago -69.29 7.17 7.22
EPS (TTM) vs TTM 1 Yr. Ago -54.63 -- --
EPS - 5 Yr. Growth Rate -- 9.91 10.92
Capital Spending - 5 Yr. Growth Rate -38.25 15.14 15.14

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.49 2.54
Current Ratio (MRQ) 15.72 3.50 3.56
LT Debt to Equity (MRQ) 0.00 11.06 13.40
Total Debt to Equity (MRQ) 0.00 17.26 19.46
Interest Coverage (TTM) -147.88 50.32 44.80

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.26 54.92
Gross Margin - 5 Yr. Avg. -- 52.35 52.46
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.39 15.49
Operating Margin (TTM) -- 14.74 6.65
Operating Margin - 5 Yr. Avg. -- 14.34 10.97
Pre-Tax Margin (TTM) -- 15.19 7.47
Pre-Tax Margin - 5 Yr. Avg. -- 14.65 11.38
Net Profit Margin (TTM) -- 11.36 3.70
Net Profit Margin - 5 Yr. Avg. -- 10.99 7.67
Effective Tax Rate (TTM) -- 24.36 24.26
Effective Tax Rate - 5 Yr. Avg. -- 23.45 24.06

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 942,675,078 848,695,288
Net Income/Employee (TTM) -- 110,066,343 99,009,570
Receivable Turnover (TTM) -- 5.90 6.11
Inventory Turnover (TTM) -- 2.73 3.55
Asset Turnover (TTM) 0.00 0.99 0.96

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -62.77 11.83 11.28
Return on Assets - 5 Yr. Avg. -136.20 12.83 12.25
Return on Investment (TTM) -70.35 15.03 14.40
Return on Investment - 5 Yr. Avg. -215.40 16.79 16.04
Return on Equity (TTM) -70.35 16.54 15.99
Return on Equity - 5 Yr. Avg. -923.65 17.80 17.25
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 51.89 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Therapix Biosciences Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.